We are live on ! Find out more

Drug Manufacturers - Specialty & Generic
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
DERM icon
51
Journey Medical
DERM
$175M
$175M $6.37 2.91%
ACB
52
Aurora Cannabis
ACB
$170M
$170M $2.74 2.62%
LFCR icon
53
Lifecore Biomedical
LFCR
$163M
$163M $4.34 0.23%
ADCT icon
54
ADC Therapeutics
ADCT
$145M
$145M $1.14 0.87%
CRDL
55
Cardiol Therapeutics
CRDL
$134M
$134M $1.16 1.69%
OGI
56
Organigram Holdings
OGI
$132M
$132M $0.9394 0.5%
BGM
57
BGM Group Ltd
BGM
$114M
$114M $0.2853 1.52%
CPIX icon
58
Cumberland Pharmaceuticals
CPIX
$105M
$105M $7.03 6.35%
ZYBT
59
Zhengye Biotechnology Holding
ZYBT
$72.5M
$72.5M $1.53 11.6%
TLPH icon
60
Talphera
TLPH
$65.4M
$65.4M $1.26 6.67%
CTOR
61
Citius Oncology
CTOR
$51.7M
$51.7M $0.5560 1.1%
INCR
62
Intercure
INCR
$51.6M
$51.6M $0.9030 6.52%
IXHL icon
63
Incannex Healthcare
IXHL
$35.7M
$35.7M $2.98 1.02%
SCYX icon
64
SCYNEXIS
SCYX
$35.5M
$35.5M $3.57 4.29%
OPTH
65
Optimi Health Corp
OPTH
$27.7M
$27.7M $4.92 5.13%
RMTI icon
66
Rockwell Medical
RMTI
$27.6M
$27.6M $7 5.58%
BTAI icon
67
BioXcel Therapeutics
BTAI
$26.8M
$26.8M $0.8670 2.3%
TXMD icon
68
TherapeuticsMD
TXMD
$24M
$24M $2.07 0.49%
AYTU icon
69
AYTU BioPharma
AYTU
$22.1M
$22.1M $2.06 4.63%
BFRI icon
70
Biofrontera
BFRI
$13.4M
$13.4M $1.05 3.67%
CABR
71
Caring Brands
CABR
$13.2M
$13.2M $1.45 0%
INM icon
72
InMed Pharmaceuticals
INM
$8.76M
$8.76M $1.64 4.09%
GELS
73
Gelteq Ltd
GELS
$7.08M
$7.08M $0.6610 5.68%
SNOA icon
74
Sonoma Pharmaceuticals
SNOA
$5.5M
$5.5M $1.15 0.88%
RDHL
75
Redhill Biopharma
RDHL
$4.26M
$4.26M $0.7000 10.5%
1 2
3
4

Drug Manufacturers - Specialty & Generic Stocks at a Glance

Specialty and generic drug manufacturers develop branded niche therapies, off-patent generics, and animal-health and cannabis products. Generics compete on price and manufacturing scale, while specialty brands carry pharma-like margins on smaller markets.

There are 83 Drug Manufacturers - Specialty & Generic industry stocks tracked by Wall St. Rank, worth a combined $341B.

The largest by market cap are Takeda Pharmaceutical (TAK) at $55.7B, Haleon (HLN) at $43.8B and Teva Pharmaceuticals (TEVA) at $36.2B.

Among institutional investors, Amneal Pharmaceuticals (AMRX) drew the most net new fund positions in Q1 2026: 80 funds opened new positions, taking total fund holders up 39 (14%) quarter-over-quarter.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q1 2026.